From Complexity to Clarity: Crafting a Global CDx Access Framework

A large biopharmaceutical company preparing to launch a targeted oncology therapy required assessing the access environment for companion diagnostics(CDx). It also required readiness to integrate a CDx access plan across key global markets. Given the varied market understanding and preparation regarding testing infrastructure, regulatory pathways, and clinical adoption, an algorithm for integrating a CDx access strategy was a critical success factor for asset launch success.

• Enabled alignment between global medical, commercial, and access teams
• Identified country-level gaps and mitigation steps
• Informed development of a CDx access strategic plan

• Prepare an algorithm to assess country dynamics and build archetypes for rapid landscape assessment across global markets.
• Mapped testing types to be used
• Developed strategic recommendations to optimize CDx rollout in sync with drug launch.